Gilead Sciences Strengthens HIV Awareness with 'CHOOSE U' Trademark and Wins Domain Dispute
Feb/13/2025
On February 5, Gilead Sciences filed a U.S. trademark application for 'CHOOSE U', reinforcing its commitment to public awareness campaigns focused on HIV and AIDS testing, diagnosis, prevention, and treatment. The move aligns with the biopharmaceutical company’s broader mission of addressing unmet medical needs, particularly in antiviral therapies. Gilead, headquartered in Foster City, CA, has long been a leader in HIV treatment, with a portfolio that includes widely recognized drugs like Truvada, Descovy, and Biktarvy. At the same time, Gilead recently secured a victory in a domain name dispute, successfully reclaiming gileadsci.com from a third party. The case, overseen by the WIPO Arbitration and Mediation Center, concluded that the disputed domain was registered and used in bad faith. The following visualization provides detailed information on Gilead’s new U.S. trademark filing.
